Related Experiment Video
Updated: May 13, 2026

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice
Published on: July 8, 2020
Pathogenesis of immunoglobulin A nephropathy
Jan Novak1, Matthew B Renfrow, Ali G Gharavi
1aSchool of Medicine, University of Alabama at Birmingham, Birmingham, Alabama bCollege of Physicians and Surgeons, Columbia University, New York, New York, USA.
Recent advances define immunoglobulin A (IgA) nephropathy as an autoimmune disease. New research identifies specific molecular and genetic defects, paving the way for novel biomarkers and treatments for this kidney condition.
Area of Science:
- Nephrology
- Immunology
- Genetics
Background:
- Immunoglobulin A (IgA) nephropathy, initially described as an IgA-IgG immune-complex disease, is now understood as an autoimmune condition.
- The pathogenesis involves a multihit process initiated by galactose-deficient IgA1 and autoantibodies, leading to immune complex deposition and kidney injury.
Purpose of the Study:
- To review recent findings on the pathogenesis and genetics of IgA nephropathy.
- To highlight advancements in understanding the molecular and genetic underpinnings of the disease.
Main Methods:
- Review of recent scientific literature and technological advancements.
- Application of high-resolution mass spectrometry to study IgA1 O-glycosylation.
- Genome-wide association studies to identify disease-associated genetic loci.
Main Results:
- Understanding of IgA nephropathy pathogenesis has evolved, defining it as an autoimmune disease with a complex pathway.
- Galactose-deficient IgA1 and specific autoantibodies are key players in immune complex formation and renal injury.
- High-resolution mass spectrometry offers molecular insights into IgA1 O-glycosylation.
- Genome-wide association studies have identified multiple genetic risk loci and their distribution.
Conclusions:
- Recent molecular and genetic findings can lead to the development of specific biomarkers for diagnosis, prognosis, and monitoring of IgA nephropathy.
- Discovery of disease-specific targets offers potential for developing new therapeutic strategies.
More Related Videos
14:18Dioscin Mediated IgA Nephropathy Alleviation by Inhibiting B Cell Activation In Vivo and Decreasing Galactose-Deficient IgA1 Production In Vitro
Published on: October 13, 2023
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Related Concept Videos
Acute Kidney Injury II: Pathophysiology
Nephrotic Syndrome I : Introduction
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Diabetic Nephropathy
Myasthenia Gravis ll: Pathophysiology
Encephalitis ll: Pathophysiology